Opportunities x Expertise: a strategy that goes beyond the portfolio
The dental market should earn over US$ 35 billion next year, which proves the rise of the segment and average annual growth of 5.59%, according to data from Research and Markets, an Irish company responsible for the survey, carried out in 2020.
Increasing market share is an excellent opportunity for prepared players. And the FGM Dental Group has been expanding its global presence and conquering new markets with a portfolio of over 400 products in esthetics, whitening, biomaterials, prosthesis, and implant lines.
The revenue of the in-office dental whitening market should grow about 28% by 2025. This data was also presented by Research and Markets, which demonstrates growth and the need for ever bolder solutions that are, at the same time, safe and practical, such as the take-home whitening gel Whiteness Perfect, awarded by Dental Advisor for three consecutive years and commercialized in over 80 countries.
The dental implant market should grow 7.9% per year by 2024. This estimate was released recently in the Dental Implants Market report by Transparency Market Research. The document also pointed out a total market value of over 8 million dollars, and the FGM solutions are ahead of their time.
In 2021, the smart and revolutionary Arcsys system, which was already present in nine countries, conquered new markets and is now also commercialized in Portugal, Iraq, Uruguay, Peru, Honduras, and Spain. This expansion resulted in an expressive 240% growth of the implant and biomaterials lines. "We aim to to surpass 25 countries in the following years. Part of this expansion is possible due to the MDR CE certification in a high-complexity product, " explained FGM CEO Bianca Mittelstädt.
Recommended by LinkedIn
The Arcsys system has a frictional morse taper connection and brought to dentistry new possibilities for planning and execution through guided surgery, which enables better results in esthetics, function, and peri-implant health. The Arcsys system allows the dentist to personalize the angulation and find the best position of the implant and prosthesis for the patient. The manufacturing process is robust and machined in high-performance Swiss lathes with special metallic alloys, enabling briefer rehabilitation, reduced appointments, and predictable and long experiences.
The credibility of the FGM brand, present in the market for 26 years, the consistent investments in R&D, infrastructure, technology, quality, and commercial strategies have enabled an expansion of the brand's global presence to over 100 countries and an export volume that surpasses 32% of the current production.
The company anticipates trends and presents technology and technical expertise with scientific evidence recognized worldwide, besides having important credentials and extremely high relevance to the market. Among them are the authorization by the FDA for the commercialization of over 20 products; the certificate of the cosmetic products notification portal (CPNP) for European countries by Obelis; the CE marking, which indicates the compliance of medical devices according to European guidelines and regulations; the ISO 13485 certification (System for the Quality Management of Medical Devices); the Certificate of Good Manufacturing Practices (CBPF, from the Portuguese Certificado de Boas Práticas de Fabricação) from ANVISA (the Brazilian National Health Regulatory Agency); and international recognitions of quality such as the Dental Advisor and Reality Ratings & Reviews seals.
Even in the face of a challenging scenario in the last three years with the COVID-19 pandemic, the company reviewed processes and defined new strategies. It launched new products, shades, and more complete solutions to meet market demands. And the group's strategic planning includes the global expansion with warehouses, more international distributors, and presence in the major exhibitions and events of the segment, besides the expansion and growth of FGM, including the construction of a new factory and of the corporate building. The inauguration of the new FGM Implants factory is predicted for 2023, and it will be even larger within a contemporary and technological concept. The Logistics Center will also be expanded, all to guarantee that the physical structure is in line with the current expansion moment of the FGM Group and the conquering of new markets.